BioNTech boosts 2021 vaccine supply forecast to 2 bn doses
Early warning system fills in gaps in infectious disease surveillance
11 January 2021Neuroscientists identify brain circuit that encodes timing of events
11 January 2021BioNTech boosts 2021 vaccine supply forecast to 2 bn doses
German company BioNTech, which developed the first coronavirus vaccine approved in the West, said Monday it expects to produce two billion doses in 2021, up from the 1.3 billion previously forecast.
